tiprankstipranks
Sunho Biologics,Inc. (HK:2898)
:2898
Hong Kong Market
2898
Sunho Biologics,Inc.
RESEARCH TOOLSreports

Sunho Biologics,Inc. (2898) Ratios

0 Followers

Sunho Biologics,Inc. Ratios

HK:2898's free cash flow for Q2 2025 was ¥1.00. For the 2025 fiscal year, HK:2898's free cash flow was decreased by ¥ and operating cash flow was ¥-2.44K. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 6.59 11.17 0.59 0.22
Quick Ratio
 6.57 11.15 0.58 0.21
Cash Ratio
 2.31 1.79 0.32 0.03
Solvency Ratio
 -0.98 -1.51 -0.31 -0.60
Operating Cash Flow Ratio
 0.15 -2.47 -0.10 -0.52
Short-Term Operating Cash Flow Coverage
 0.18 -3.18 0.00 -7.18
Net Current Asset Value
¥ 411.45M¥ 444.20M¥ -167.42M¥ -57.73M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.07 0.03 0.16
Debt-to-Equity Ratio
 0.14 0.08 -0.09 -7.35
Debt-to-Capital Ratio
 0.12 0.07 -0.10 1.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 1.32
Financial Leverage Ratio
 1.16 1.10 -2.79 -47.27
Debt Service Coverage Ratio
 -1.36 -2.77 -178.28 -3.85
Interest Coverage Ratio
 0.00 0.00 -95.68 -11.21
Debt to Market Cap
 0.07 0.08 0.00 <0.01
Interest Debt Per Share
 0.45 0.32 0.11 0.18
Net Debt to EBITDA
 1.24 0.40 0.94 -0.24
Profitability Margins
Gross Profit Margin
100.00%100.00%0.79%27.33%
EBIT Margin
-528488.24%-266723.68%-752.87%-2710.23%
EBITDA Margin
-488744.12%-249876.32%-703.60%-2201.39%
Operating Profit Margin
-528488.24%-266723.68%-377.60%-3285.90%
Pretax Profit Margin
-482864.71%-210434.21%-756.82%-3003.35%
Net Profit Margin
-482864.71%-210434.21%-756.82%-3003.35%
Continuous Operations Profit Margin
-482864.71%-210434.21%-756.82%-3003.35%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
91.37%78.90%200.43%91.40%
Return on Assets (ROA)
-14.71%-14.26%-45.69%-73.37%
Return on Equity (ROE)
-16.53%-15.62%127.46%3468.18%
Return on Capital Employed (ROCE)
-18.57%-19.62%68.11%-1208.39%
Return on Invested Capital (ROIC)
-16.35%-18.32%69.67%-597.09%
Return on Tangible Assets
-14.98%-14.52%-47.32%-85.42%
Earnings Yield
-9.70%-17.56%-10.86%-4.45%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 13.61 0.52
Payables Turnover
 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.09 1.43
Fixed Asset Turnover
 <0.01 <0.01 0.35 0.04
Asset Turnover
 <0.01 <0.01 0.06 0.02
Working Capital Turnover Ratio
 <0.01 <0.01 -0.17 -0.04
Cash Conversion Cycle
 0.00 0.00 4.29K 955.67
Days of Sales Outstanding
 0.00 0.00 26.81 700.06
Days of Inventory Outstanding
 0.00 0.00 4.27K 255.62
Days of Payables Outstanding
 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 4.29K 955.67
Cash Flow Ratios
Operating Cash Flow Per Share
 0.07 -0.85 -0.44 -0.38
Free Cash Flow Per Share
 -0.15 -1.23 -0.45 -0.39
CapEx Per Share
 0.23 0.38 0.01 0.02
Free Cash Flow to Operating Cash Flow
 -2.06 1.45 1.03 1.04
Dividend Paid and CapEx Coverage Ratio
 0.33 -2.21 -39.47 -24.03
Capital Expenditure Coverage Ratio
 0.33 -2.21 -39.47 -24.03
Operating Cash Flow Coverage Ratio
 0.16 -2.65 -4.48 -3.14
Operating Cash Flow to Sales Ratio
 657.53 -2.87K -2.32 -19.98
Free Cash Flow Yield
-2.62%-34.75%-3.41%-3.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.31 -5.70 -9.21 -22.49
Price-to-Sales (P/S) Ratio
 51.70K 11.99K 69.69 675.55
Price-to-Book (P/B) Ratio
 1.76 0.89 -11.74 -780.11
Price-to-Free Cash Flow (P/FCF) Ratio
 -38.10 -2.88 -29.32 -32.46
Price-to-Operating Cash Flow Ratio
 75.74 -4.18 -30.06 -33.81
Price-to-Earnings Growth (PEG) Ratio
 -0.80 0.10 -0.06 0.84
Price-to-Fair Value
 1.76 0.89 -11.74 -780.11
Enterprise Value Multiple
 -9.34 -4.40 -8.97 -30.93
Enterprise Value
 775.84M 417.67M 1.11B 1.18B
EV to EBITDA
 -9.34 -4.40 -8.97 -30.93
EV to Sales
 45.64K 10.99K 63.08 680.87
EV to Free Cash Flow
 -33.64 -2.64 -26.53 -32.72
EV to Operating Cash Flow
 69.41 -3.83 -27.21 -34.08
Tangible Book Value Per Share
 3.12 3.89 -1.23 -0.13
Shareholders’ Equity Per Share
 3.19 3.97 -1.12 -0.02
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 0.19 0.02
Net Income Per Share
 -0.54 -0.62 -1.43 -0.57
Tax Burden
 1.00 1.00 1.00 1.00
Interest Burden
 0.91 0.79 1.01 1.11
Research & Development to Revenue
 3.66K 1.87K 2.45 30.72
SG&A to Revenue
 1.63K 796.74 2.32 3.21
Stock-Based Compensation to Revenue
 864.53 746.00 1.72 1.18
Income Quality
 -0.14 1.36 0.31 0.67
Currency in CNY